Related Experiment Video
Updated: Sep 13, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Expression of mitotic Aurora/Ipl1p-related kinases in renal cell carcinomas: an immunohistochemical study
Hidetoshi Ehara1, Shigeaki Yokoi, Masayoshi Tamaki
1Department of Urology, Gifu University School of Medicine, 40 Tsukasa, Gifu 500-8705, Japan. h-ehara@cc.gifu-u.ac.jp
Abstract:
The Aurora/Ipl1p-related kinases, AIRK1, AIRK2 and AIRK3, are members of a novel family of oncogenic serine/threonine kinases regulated by cell cycle progression and involved in chromosome segregation and cytokinesis. In this study, we examined expression of members of the AIRK family in human renal cell carcinomas. Expression of AIRK subfamilies was examined in 64 renal cell carcinomas by immunohistochemistry. Immunostaining of AIRK1, AIRK2 and AIRK3 was observed in 95%, 47% and 98% of specimens, respectively. Moreover, in specimens from the same patient, staining of AIRK2 was correlated with proliferating cell nuclear antigen labeling. Here we provide the first description of AIRK isozyme immunostaining in human renal cell carcinoma. Although the precise physiological functions of these kinases are not known, AIRK subfamily expression may play a role in renal cell carcinoma tumorigenesis.
Insights
This study investigated Aurora/Ipl1p-related kinases (AIRK1, AIRK2, AIRK3) in human renal cell carcinoma. High expression of AIRK1 and AIRK3, and correlation of AIRK2 with proliferation, suggest a role in kidney cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Aurora/Ipl1p-related kinases (AIRK1, AIRK2, AIRK3) are oncogenic serine/threonine kinases.
- These kinases are involved in cell cycle regulation, chromosome segregation, and cytokinesis.
Purpose of the Study:
- To examine the expression of AIRK1, AIRK2, and AIRK3 in human renal cell carcinomas.
- To investigate the potential role of AIRK subfamily expression in renal cell carcinoma tumorigenesis.
Main Methods:
- Immunohistochemistry was used to assess AIRK subfamily expression in 64 renal cell carcinoma specimens.
- Correlation between AIRK2 staining and proliferating cell nuclear antigen (PCNA) labeling was analyzed.
Main Results:
- AIRK1, AIRK2, and AIRK3 immunostaining was detected in 95%, 47%, and 98% of renal cell carcinoma specimens, respectively.
- AIRK2 staining showed a positive correlation with PCNA labeling in specimens from the same patient.
- This study presents the first description of AIRK isozyme immunostaining in human renal cell carcinoma.
Conclusions:
- AIRK subfamily expression is prevalent in human renal cell carcinoma.
- The observed expression patterns and correlation with proliferation markers suggest that AIRK kinases may contribute to renal cell carcinoma development.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
